Xilio Therapeutics, Inc. (XLO)

NCM – Цена в реальном времени. Валюта: USD

9.19

-0.01 (-0.11%)

При закрытии: Aug 11, 2026, 3:20 PM EDT

8.50

-0.69 (-7.51%)

До открытия: Aug 12, 2026, 8:33 AM EDT

12.08.2026

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Received FDA clearance of IND application for XTX501, a potential best-in-class bispecific PD-1 / masked IL-2 Advancing IND-enabling studies for potential first-in-class multi-specific, masked T cell engager programs targeting CLDN18.2 and PSMA+STEAP1; IND applications anticipated in the second half of 2027 Cash runway into the first quarter of 2028 expected to support key milestones across pipeline of next generation multi-specific I-O therapies WALTHAM, Mass., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing masked immuno-oncology therapies for people living with cancer, today announced pipeline progress and business updates and reported financial results for the second quarter ended June 30, 2026.

Видео

No Data

There is no data to display

Пресс-релизы

12.08.2026

Xilio Therapeutics, Inc. (XLO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Видео

No Data

Пресс-релизы

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Видео

No Data

Пресс-релизы

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Search stocks

Xilio Therapeutics, Inc. (XLO)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Xilio Therapeutics, Inc. (XLO)

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Видео

No Data

Пресс-релизы

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates

Видео

No Data

Пресс-релизы

Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates